PB 105 of 2020

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No. 9)

I, PAUL HANSEN, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health make the following determination.

Dated    29 October 2020

PAUL HANSEN  

Contents

1 Name

2 Commencement

3 Authority

4  Schedule

Schedule 1—Amendments 2

National Health (Continued Dispensing - Emergency Measures) Determination 2020 2

1  Name

(1)  This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No. 9).

(2)  This instrument may also be cited as PB 105 of 2020.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

[1]           Schedule 1, omit entry for Aurothiomalate

[2]           Schedule 1, entry for Flucloxacillin

(a)           omit:

(b)           omit:

[3]           Schedule 1, entry for Glyceryl trinitrate

omit:

[4]           Schedule 1, entry for Glycomacropeptide and essential amino acid formula with vitamins, minerals, and low in tyrosine and phenylalanine

insert as first entry:

[5]           Schedule 1, entry for Ketoconazole

omit:

[6]           Schedule 1, entry for Nifedipine

 omit:

[7]           Schedule 1, entry for Periciazine

(a)           omit:

(b)           omit:

[8]           Schedule 1, entry for Phenoxybenzamine

omit:

[9]           Schedule 1, omit entry for Pneumococcal vaccine ‑ polyvalent

[10]       Schedule 1, entry for Quinagolide

omit:

[11]       Schedule 1, after entry for Simvastatin in the form Tablet 80 mg

insert:

[12]       Schedule 1, omit entry for Sofosbuvir